Log on / register
Feedback | Support | My details
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab.
Baraliakos X, Listing J, Brandt J, Zink A, Alten R, Burmester G, Gromnica-Ihle E, Kellner H, Schneider M, Sörensen H, Zeidler H, Rudwaleit M, Sieper J, Braun J
Arthritis Res Ther 2005, 7:R439-44
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
37%37%


 Review    
Developments in the scientific and clinical understanding of the spondyloarthritides
Sieper J
Arthritis Research & Therapy 2009, 11:208 (30 January 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.
37%37%


 Correction    
Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
Baraliakos X, Listing J, Brandt J, Zink A, Alten R, Burmester G, Gromnica-Ihle E, Kellner H, Schneider M, Sörensen H, Zeidler H, Rudwaleit M, Sieper J, Braun J
Arthritis Research & Therapy 2005, 7:113 (23 March 2005)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

This article is also cited by a further 5 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.